AzTrials
AzTrials

Long COVID-19 SyndromeTRCovidANCT04742946

Digital Physiotherapy Practice in Long Covid-19 Patients

A study testing Digital Physiotherapy Practice (Telerehabilitation) in people with Long COVID-19 Syndrome, run by Universidad de Granada at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The COVID-19 can cause important sequels in the respiratory system by bilateral pneumonia and frequently presents loss of strength, dyspnea, polyneuropathies and multi-organic affectation. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Long COVID-19 Syndrome
What is being tested?
Digital Physiotherapy Practice (Telerehabilitation)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
27 participants
Where
1 siteSpain
Study dates
15 Dec 2021to 30 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Adult over 18 years old
  • Diagnosis: Long COVID-19 syndrome
  • Residing in the Andalusian Community during the research period
  • To have a computer technology with an internet connection aat home (personal computer, laptop, tablet or smartphone)
  • Ability and knowledge to access email or whatsapp

Who cannot join

  • -Cognitive ability not suitable for the use of technological tools

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Facultad Ciencias de la Salud

    Málaga, 29004

Other trials in Spain

About this study

Official title: Digital Physiotherapy Practice in Long Covid-19 Patients to Improve Functional Capacity and Quality of Life.

The COVID-19 can cause important sequels in the respiratory system by bilateral pneumonia and frequently presents loss of strength, dyspnea, polyneuropathies and multi-organic affectation. Long COVID-19 has been defined as the condition occurring in individuals with a history of probable or confirmed SARS-CoV-2 infection, with related symptoms lasting at least 2 months and not explainable by an alternative diagnosis. The practice of digital physiotherapy presents itself as a promising complementary treatment method to standard physiotherapy, playing a key role in the recovery of function in subjects who have passed the disease and who maintain some symptomatology over time. The aims of this research are to explore the effect of a digital physiotherapy intervention on functional recovery in patients diagnosed with Long COVID-19 and to identify the level of adherence to the treatment carried out. Physiotherapy interventions acquires a fundamental role in the recovery of the functions and the quality of life. As secondary objectives, the aim is to identify the satisfaction and perception of patients with the intervention and the presence of barriers to its implementation (throught a qualitative research), as well as to evaluate the cost-effectiveness from the perspective of the health system. A quasi-experimental pre-post study assessed initially and at the end of the 4-week intervention the functional capacity (1-min STS and SPPB) and the adherence (software). The hypothesis of this research is that the implementation of a TR program presents positive results. If hypothesis is confirmed, that would be an opportunity to define new policies and interventions to address this disease and its consequences.

Read the detailed description

The authors hypothesised that the implementation of a digital physiotherapy intervention in Long COVID-19 participants is effective to improve the functional capacity and adherence and have positive results in patients satisfaction.

Being tested
Digital Physiotherapy Practice (Telerehabilitation)
Keywords
Digital Physiotherapy Practice (Telerehabilitation), Covid19 sequelae
Medical subject headings
Post-Acute COVID-19 Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Digital Physiotherapy Practice (Telerehabilitation)Other

    Also called Telemedicine, ehealth

    Online Physiotherapy services

Study groups in NCT04742946
Study groupRoleWhat they receive
TR GroupExperimentalPersonalized digital physiotherapy program 4 weeks. One session per day. Web and mobile application. Auto-Exercise
Receives: Other: Digital Physiotherapy Practice (Telerehabilitation)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Functional Capacity

    sit-to-stand test in 1 minute

    Measured: Baseline (T0)

  2. Functional Capacity

    sit-to-stand test in 1 minute

    Measured: 4 weeks (T1)

  3. Functional Capacity (SPBB) short performance physical battery test

    (SPBB) short performance physical battery test

    Measured: Baseline (T0)

  4. Functional Capacity (SPBB) short performance physical battery test

    (SPBB) short performance physical battery test

    Measured: Baseline 4 weeks (T1)

  5. The Short Form Health Survey SF-12

    Quality of Live. For each of the 8 dimensions, the items are coded, aggregated and transformed into a scale ranging from 0 (the worst health status for that dimension) to 0 (the worst health status for that dimension).

    a scale ranging from 0 (the worst health status for that dimension) to 100 (the best health status).

    100 (the best health status)

    Measured: Baseline (T0)

  6. The Short Form Health Survey SF-12 Quality of Live

    The SF-12 For each of the 8 dimensions, the items are coded, aggregated and transformed into a scale ranging from 0 (the worst health status for that dimension) to 0 (the worst health status for that dimension).

    a scale ranging from 0 (the worst health status for that dimension) to 100 (the best health status).

    100 (the best health status)

    Measured: 4 weeks (T1)

  7. European Quality of Life-5 Dimensions EQ-5D

    Quality of Live The responses to the five EQ-5D dimensions (i.e. an EQ-5D health state or profile) can be converted into a single number called an index value. The index value reflects how good or bad the health state is according to the preferences of the general population of a country/region. The collection of index values for all possible EQ-5D states is called a value set. Value sets are currently available for the EQ-5D-3L and EQ-5D-5L for different countries/regions. Several valuation techniques have been used to generate these value sets: time trade-off (TTO), visual analogue scale (VAS), and more recently, discrete choice experiments (DCE).

    Measured: Baseline (T0)

  8. European Quality of Life-5 Dimensions EQ-5D

    Quality of Live The responses to the five EQ-5D dimensions (i.e. an EQ-5D health state or profile) can be converted into a single number called an index value. The index value reflects how good or bad the health state is according to the preferences of the general population of a country/region. The collection of index values for all possible EQ-5D states is called a value set. Value sets are currently available for the EQ-5D-3L and EQ-5D-5L for different countries/regions. Several valuation techniques have been used to generate these value sets: time trade-off (TTO), visual analogue scale (VAS), and more recently, discrete choice experiments (DCE).

    Measured: 4 weeks (T1)

Secondary outcomes (4)
  1. Telemedicine Satisfaction Questionnaire (TSQ)

    Telemedicine Satisfaction Questionnaire (TSQ). Perceived satisfaction comparing telemedicine to inperson in 26 Questions with likert scales

    Measured: 4 weeks (T1)

  2. Cost-effectiveness of the telerehabilitation intervention

    Direct Costs

    Measured: 4 weeks T1

  3. Adherence to intervention

    Automatic register by the digital physiotherapy software. Number of treatments and exercise acoording to PT prescription.

    Measured: 4 weeks T1

  4. Satisfaction and Perception with intervention

    Qualitative interview

    Measured: 4 weeks T1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Feb 2021
  2. Study start15 Dec 2021
  3. Primary completion30 Dec 2022 (estimated)
  4. Study completion30 Dec 2022 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
A quasi-experimental pre-post study
Masking
None (open label)
Enrolment
27 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04742946
Sponsor's protocol ID
TRCovidAndalucía
Acronym
TRCovidA
Status last verified
Nov 2022
First submitted
3 Feb 2021
Last updated
18 Nov 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Study protocol, Statistical Analysis plan and outcomes measures will be shared

Publications

  • Del Rio C, Malani PN. 2019 Novel Coronavirus-Important Information for Clinicians. JAMA. 2020 Mar 17;323(11):1039-1040. doi: 10.1001/jama.2020.1490. No abstract available.

    PubMed 32022836
  • Sohrabi C, Alsafi Z, O'Neill N, Khan M, Kerwan A, Al-Jabir A, Iosifidis C, Agha R. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg. 2020 Apr;76:71-76. doi: 10.1016/j.ijsu.2020.02.034. Epub 2020 Feb 26.

    PubMed 32112977
  • Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, Li P, Zhou Y, Lin YF, Duan Q, Luo G, Fan S, Lu Y, Feng A, Zhan Y, Liang B, Cai W, Zhang L, Du X, Li L, Shu Y, Zou H. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. J Infect. 2020 Jun;80(6):656-665. doi: 10.1016/j.jinf.2020.03.041. Epub 2020 Apr 10.

    PubMed 32283155
  • Estebanez-Perez MJ, Martin-Valero R, Pastora-Estebanez P, Pastora-Bernal JM. Experiences of people with Long Covid with a digital physiotherapy intervention: A qualitative study. Health Expect. 2024 Apr;27(2):e13993. doi: 10.1111/hex.13993.

    PubMed 38590093
  • Estebanez-Perez MJ, Pastora-Bernal JM, Vinolo-Gil MJ, Pastora-Estebanez P, Martin-Valero R. Digital physiotherapy is a satisfactory and effective method to improve the quality of life in Long COVID patients. Digit Health. 2024 Feb 26;10:20552076241234432. doi: 10.1177/20552076241234432. eCollection 2024 Jan-Dec.

    PubMed 38414563
  • Estebanez-Perez MJ, Pastora-Bernal JM, Martin-Valero R. The Effectiveness of a Four-Week Digital Physiotherapy Intervention to Improve Functional Capacity and Adherence to Intervention in Patients with Long COVID-19. Int J Environ Res Public Health. 2022 Aug 3;19(15):9566. doi: 10.3390/ijerph19159566.

    PubMed 35954922
  • Pastora-Bernal JM, Estebanez-Perez MJ, Molina-Torres G, Garcia-Lopez FJ, Sobrino-Sanchez R, Martin-Valero R. Telerehabilitation Intervention in Patients with COVID-19 after Hospital Discharge to Improve Functional Capacity and Quality of Life. Study Protocol for a Multicenter Randomized Clinical Trial. Int J Environ Res Public Health. 2021 Mar 12;18(6):2924. doi: 10.3390/ijerph18062924.

    PubMed 33809277

Questions about this trial

What is this clinical trial studying?

A study testing Digital Physiotherapy Practice (Telerehabilitation) in people with Long COVID-19 Syndrome, run by Universidad de Granada at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Functional Capacity (time frame: Baseline (T0)). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04742946, which also lists 7 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Nov 2022.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in